145-41-5 Usage
Description
Sodium dehydrocholate, also known as Decholin Sodium, is a bile acid derivative obtained from the glycopeptide antibiotic complex found in Actinoplanes teichomyceticus. It is structurally related to vancomycin and is comprised of five major components, differentiated by a specific fatty acid moiety. Sodium dehydrocholate possesses a melting point greater than 300°C and is known for its choleretic properties, which means it promotes the flow of bile from the liver to the small intestine.
Uses
Used in Pharmaceutical Industry:
Sodium dehydrocholate is used as a pharmaceutical agent for its choleretic properties, aiding in the treatment of various liver and gallbladder disorders. It helps in the flow of bile, which is essential for the digestion and absorption of fats and fat-soluble vitamins.
Used in Research and Development:
Sodium dehydrocholate is used as a research compound to study biliary excretion, which is the process of bile being excreted from the liver into the small intestine. Sodium dehydrocholate helps researchers understand the mechanisms and factors involved in bile excretion, leading to the development of new treatments for related health conditions.
Used in Drug Delivery Systems:
In the field of drug delivery, sodium dehydrocholate is used as a component in the formulation of various drug delivery systems. Its ability to interact with biopolymers and macromolecules makes it a valuable tool in enhancing the delivery, bioavailability, and therapeutic outcomes of certain drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 145-41-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,4 and 5 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 145-41:
(5*1)+(4*4)+(3*5)+(2*4)+(1*1)=45
45 % 10 = 5
So 145-41-5 is a valid CAS Registry Number.
InChI:InChI=1/C24H34O5.Na/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26;/h13-14,16-18,22H,4-12H2,1-3H3,(H,28,29);/q;+1/p-1/t13-,14+,16-,17+,18+,22+,23+,24-;/m1./s1
145-41-5Relevant articles and documents
Platinum complexes containing chemically modified bile acids, having antitumor activity
-
Page/Page column 2-3; 6, (2010/02/11)
The present invention relates to platinum complexes containing bile acid derivatives having antitumor activity